BR0010521A - Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação - Google Patents

Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação

Info

Publication number
BR0010521A
BR0010521A BR0010521-0A BR0010521A BR0010521A BR 0010521 A BR0010521 A BR 0010521A BR 0010521 A BR0010521 A BR 0010521A BR 0010521 A BR0010521 A BR 0010521A
Authority
BR
Brazil
Prior art keywords
floroglucinol
preparation
oral administration
pharmaceutical compositions
compositions
Prior art date
Application number
BR0010521-0A
Other languages
English (en)
Inventor
Abderrahim Bennis
Jean-Jacques Serrano
Farid Bennis
Original Assignee
Promindus Actions Promotionnel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promindus Actions Promotionnel filed Critical Promindus Actions Promotionnel
Publication of BR0010521A publication Critical patent/BR0010521A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS DESTINADAS A ADMINISTRAçãO POR VIA ORAL DE FLOROGLUCINOL E SUA PREPARAçãO". A presente invenção tem por objetivo as composições farmacêuticas, destinadas a administração por via oral de floroglucinol, assim como sua preparação. De modo característico, as ditas composições: - líquidas, encerram um sistema que as tamponam a um pH compreendido entre 3 e 7; - sólidos, encerram um sistema capaz de exercer, quando de sua colocação em meio aquoso, um efeito tampão entre pH 3 e pH 7. As ditas composições consistem vantajosamente de comprimidos efervescentes.
BR0010521-0A 1999-05-19 2000-05-19 Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação BR0010521A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906325A FR2793685B1 (fr) 1999-05-19 1999-05-19 Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation
PCT/FR2000/001365 WO2000071110A1 (fr) 1999-05-19 2000-05-19 Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation

Publications (1)

Publication Number Publication Date
BR0010521A true BR0010521A (pt) 2002-02-19

Family

ID=9545742

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010521-0A BR0010521A (pt) 1999-05-19 2000-05-19 Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação

Country Status (12)

Country Link
EP (1) EP1178787B1 (pt)
AT (1) ATE245974T1 (pt)
AU (1) AU4929400A (pt)
BR (1) BR0010521A (pt)
DE (1) DE60004204T2 (pt)
ES (1) ES2203477T3 (pt)
FR (1) FR2793685B1 (pt)
HK (1) HK1045937B (pt)
MA (1) MA26788A1 (pt)
MX (1) MXPA01011842A (pt)
PT (1) PT1178787E (pt)
WO (1) WO2000071110A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1345592A2 (en) * 2000-12-06 2003-09-24 Pharmacia Corporation Rapidly dispersing pharmaceutical composition comprising effervescent agents
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
JP5762666B2 (ja) * 2004-10-12 2015-08-12 ボード、オブ、トラスティーズ、オブ、ミシガン、ステイト、ユニバーシティＢｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｍｉｃｈｉｇａｎ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ フロログルシノールの生合成およびそれからの１，３−ジヒドロキシベンゼンの製造
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
FR2912654B1 (fr) * 2007-02-19 2009-12-25 Rech En Toxicologie Et Pharmac Association medicamenteuse comprenant du phloroglucinol et du paracetamol
KR101079042B1 (ko) * 2008-12-01 2011-11-02 부경대학교 산학협력단 항-ｈｉｖ-1 저해 활성을 갖는 감태 유래 플로로글루시놀 유도체
FR2956815B1 (fr) * 2010-02-26 2012-09-28 Delpharm Sa Nouveau procede de production de forme injectables a base de phloroglucinol et les formes injectables ainsi realisees
FR3060391A1 (fr) * 2016-12-20 2018-06-22 Promindus Sarl Composition pharmaceutique anti douleur
CN115715758B (zh) * 2022-12-09 2023-11-03 河北赛谱睿思医药科技有限公司 一种间苯三酚口服液及其生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB904955A (en) * 1959-12-30 1962-09-05 Orsymonde Pharmaceutical compositions containing phloroglucinol
FR1569456A (pt) * 1967-07-04 1969-05-30
FR2665357B1 (fr) * 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
FR2709959B1 (fr) * 1993-09-14 1995-12-08 Lafon Labor Nouvelle forme galénique de phloroglucinol.
FR2722408B1 (fr) * 1994-07-15 1996-10-04 Vacher Dominique Nouveau procede de realisation de formes pharmaceutiques seches a delitement quasiment instantane etles formes pharmaceutiques ainsi realisees
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable

Also Published As

Publication number Publication date
DE60004204T2 (de) 2004-04-15
EP1178787A1 (fr) 2002-02-13
MXPA01011842A (es) 2003-09-04
DE60004204D1 (de) 2003-09-04
ATE245974T1 (de) 2003-08-15
HK1045937B (zh) 2004-01-16
HK1045937A1 (en) 2002-12-20
WO2000071110A1 (fr) 2000-11-30
MA26788A1 (fr) 2004-12-20
EP1178787B1 (fr) 2003-07-30
FR2793685A1 (fr) 2000-11-24
PT1178787E (pt) 2003-11-28
AU4929400A (en) 2000-12-12
FR2793685B1 (fr) 2001-08-24
ES2203477T3 (es) 2004-04-16

Similar Documents

Publication Publication Date Title
BR9913626A (pt) Formulações de ranolazina de liberação contìnua
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
TW355683B (en) Composition containing micronized nebivolol
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
PL346764A1 (en) New oral formulation for 5-ht4
BR0211736A (pt) Formulação para suspensão oral estabilizada
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
BG108516A (en) Pharmaceutical formulation
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
WO2001010408A3 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AP2001002369A0 (en) Pharmaceutical complex.
WO2001022917A3 (en) Effervescent compositions comprising nimesulide
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
GR3019776T3 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
AU6473699A (en) Aqueous drug formulation for oral application
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.